Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
Who gets immunomodulators?
Source: Presentation - ECCO 2016 Amsterdam Congress - 3rd Basic ECCO: EduCational COurse for Industry : Session 2 (Keywords: clinical trials)
Authors: Vipul Jairath
Who should do the pouch surgery (credentialing, learning curve)
Source: Presentation - ECCO 2013 Vienna Congress - 2nd S-ECCO IBD Masterclass - Session 2: The ileoanal pouch
Authors: Zane Cohen
Why are paediatric GI doctors obsessed with nutrition?
Source: Presentation - ECCO 2014 Copenhagen Congress - Update on Paediatric IBD: Why are paediatric GI doctors obsessed with nutrition?
Authors: Frank Ruemmele
Workshop 1 UC Management (Group A)
Source: Presentation - ECCO 2015 Barcelona Congress - 6th N-ECCO School Session 2: Case studies – Disease management (anti-TNF, AZA, disease outcome, UC, trials, vedolizumab)
Authors: Sturm Andreas
Workshop 1 – CD Management
Source: Presentation - ECCO 2013 Vienna Congress - 4th N-ECCO School - Session 2: Case studies - Disease management
Authors: Jean-Frederic Colombel
Workshop 1 – UC Management
Source: Presentation - ECCO 2013 Vienna Congress - 4th N-ECCO School - Session 2: Case studies - Disease management
Authors: Sandro Ardizzone
Workshop 1 – UC Management
Source: Presentation - ECCO 2014 Copenhagen Congress - 5th N-ECCO School - Session 2: Case studies – Disease management: Workshop 1 – UC Management
Authors: Andreas Sturm
Workshop 2 CD Management (Group B)
Source: Presentation - ECCO 2015 Barcelona Congress - "6th N-ECCO School Session 2b: Case studies – Disease management (CD)
Y-ECCO Literature Review: 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomized trial.
Source: ECCO News Issue 02/2011
Authors: Anja Schirbel
Y-ECCO Literature Review: A CD3-specific antibody reduces cytokine production and alters phospho-protein profiles in intestinal tissues from patients with Inflammatory Bowel Disease
Source: ECCO News Issue 02/2014
Authors: Raquel Cabezón
Y-ECCO Literature Review: A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease
Source: ECCO News Issue 04/2014
Authors: Nuha Yassin
Y-ECCO Literature Review: A population-based study of fatigue and sleep difficulties in inflammatory bowel disease
Source: ECCO News Issue 04/2011
Authors: Antonina Mikocka-Walus
Y-ECCO Literature Review: A prospective study of long-term intake of dietary fibre and risk of Crohn’s disease and ulcerative colitis
Source: ECCO News Issue 04/2013
Authors: Robin Dart
Y-ECCO Literature Review: Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn’s Disease
Source: ECCO News Issue 04/2012
Authors: J. Jasper Deuring
Y-ECCO Literature Review: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: a randomised, doubleblind, placebo-controlled trial (ADAFI)
Source: ECCO News Issue 02/2013
Authors: Ilse Molendijk
Y-ECCO Literature Review: Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn’s disease: a randomised, doubleblind, placebo-controlled trial (ADAFI)
Source: ECCO News Issue 02/2013
Authors: Ilse Molendijk
Y-ECCO Literature Review: AIM2 contributes to the maintenance of intestinal integrity via Akt and protects against Salmonella mucosal infection
Source: ECCO News Issue 02/2016
Authors: Wiebe Vanhove
Y-ECCO Literature Review: Alterations in mucin glycosylation are associated with spontaneous colitis
Source: ECCO News Issue 03/2011
Authors: Sebastian Zeissig
Y-ECCO Literature Review: Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study
Source: ECCO News Issue 02/2013
Authors: Dominik Bettenworth
Y-ECCO Literature Review: Antibodies to adalimumab are associated with future inflammation in Crohn’s patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
Source: ECCO News Issue 02/2015
Authors: Nik Sheng Ding